ARCHIVES

Nader Group Backs FDA In controversy Over Drug Testing

This article is from The Cancer Letter archive.

Vol. 03 No. 06 | February 11, 1977

Download PDF Visit The Full Archive

Related Articles

In Brief: Recompetition Of Frederick Contract Flops, As Others Leave The Field To Litton-Bionetics

April 15, 1977

NCI Advisory Group, Other Cancer Meetings

July 25, 1986

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007

CMS Advisors Express Low Confidence In Low-Dose CT Screening for Lung Cancer

May 9, 2014

ASCO/AUA Suggest 5-ARIs To Cut Prostate Cancer Risk

February 27, 2009

Freireich’s Seven Laws To Protect Against Obstacles To Clinical Research

May 14, 1976